2 April 2026
Pakistani weightlifter Abubakar Ghani has also been sanctioned by the CAS ADD with a four-year period of ineligibility for tampering.
After hearing the parties and upon consideration of the written submissions and evidence, on 20 March 2026, the CAS ADD issued its decision concluding that Mr Hafiz Imran Butt and Mr Irfan Butt had each committed ADRVs under Article 2.8 (Administration of a Prohibited Substance) of the IWF ADR. Notably, the CAS ADD found that both athlete support personnel had been directly involved in the administration of prohibited substances, including steroids, to Pakistani athletes, including minors, and had played central roles in large-scale doping in Pakistan, having actively and continuously engaged in doping practices.
Given the nature and severity of their conduct, each individual was sanctioned with the maximum period of ineligibility applicable, being a lifetime ban. In application of this sanction, both Mr Hafiz Imran Butt and Mr Irfan Butt shall thus be prevented from participating in any activity authorised or organised by any signatory of the World Anti-Doping Code in any capacity whatsoever.
Mr Hafiz Imran Butt and Mr Irfan Butt, as well as the relevant stakeholders, namely IWF/the ITA, the World Anti-Doping Agency (WADA) and the Pakistan National Anti-Doping Organisation, have a right to appeal the decision before the appeal division of the Court of Arbitration for Sport.
The athlete had previously served a two-year period of ineligibility from 1 February 2022 to 31 January 2024 for the Presence and/or Use of a Prohibited Substance under Article 2.1 and/or 2.2 of the IWF ADR, after a sample collected from him on 9 December 2021 during the 2021 IWF World Championships in Tashkent had yielded an Adverse Analytical Finding (AAF) for the presence of tamoxifen metabolite. During these proceedings, the athlete had provided a number of different explanations for the AAF, supported by copies of two prescriptions that the athlete alleged to have been issued by his doctor. The matter had been resolved through an agreement on consequences pursuant to Article 8.3.3 of the IWF ADR, which the ITA and the athlete had signed on 1 September 2022.
Subsequently, during the wider investigations conducted by the ITA concerning the PWLF, it was revealed that the athlete had intentionally falsified the medical prescriptions which he had submitted to the ITA in support of his explanations regarding his AAF for tamoxifen. Consequently, the athlete was charged by the ITA on 19 May 2025 with an ADRV under Article 2.5 of the IWF ADR for tampering with the doping control process. The case was referred to the CAS ADD for adjudication and CAS ADD confirmed the ADRV and imposed a four-year period of ineligibility against the athlete, which commenced on the date the decision was issued, being 6 March 2026, and will remain in effect until 5 March 2030.
The athlete and the relevant stakeholders, namely IWF/the ITA, the World Anti-Doping Agency (WADA) and the Pakistan National Anti-Doping Organisation, have a right to appeal the decision before the appeal division of the Court of Arbitration for Sport.
No further comments will be made on these cases.
¹ According to Article 12.3 of the IWF ADR, member federations can be suspended, fined and/or have other rights withdrawn when three or more athletes, officials or athlete support personnel of the member federation are found to have committed ADRVs within a 12-month period.